Asian Journal of Urology is a premier open-access scholarly journal dedicated to advancing the field of urology. Published by Elsevier Singapore Pte Ltd, this journal provides a platform for researchers, clinicians, and students to share impactful findings and innovative practices within urological sciences. Since its inception in 2014, it has established itself as a significant contributor to the discourse in urology, achieving a commendable Q2 ranking in the category of Urology for 2023 and securing the 41st position out of 120 in Scopus rankings, placing it in the 66th percentile amongst its peers. With a commitment to ensuring broad accessibility, all articles are freely available online, promoting widespread dissemination of knowledge. The journal aims to publish high-quality research that informs clinical practices and contributes to the development of urological sciences, making it an essential resource for professionals and scholars in the field.

PROGRES EN UROLOGIE is a renowned academic journal published by Elsevier Masson, Corp Off that focuses on the dynamic field of urology. With an ISSN of 1166-7087 and an E-ISSN of 2405-5131, this journal has been contributing to the scientific community since its inception in 1991 and continues to disseminate valuable research findings to urologists and medical professionals. As of 2023, it holds a distinguished position within the Q3 category in Urology, reflecting its commitment to publishing high-quality and impactful research—ranked 74th out of 120 in the Scopus Urology category, placing it in the 38th percentile. While it does not currently offer open access options, the journal remains an essential resource for researchers seeking to advance their understanding of the latest urological practices and innovations. Its contributions are vital in a rapidly evolving medical landscape, ensuring that both established and emerging issues in urology are thoroughly explored and discussed.

Prostate International is a leading open-access journal published by Elsevier Inc, dedicated to advancing research and knowledge in the field of urology, particularly focusing on prostate health and disease. Since its inception in 2013, the journal has preserved its commitment to disseminating high-quality, peer-reviewed articles that contribute significantly to clinical practices and scientific understanding. With an impressive Q1 ranking in urology and a current position as rank #35/120 among urology journals in Scopus, it occupies a prominent place in the academic landscape, ensuring that cutting-edge research reaches a broad audience. The journal's open-access policy enhances visibility and accessibility, fostering collaboration among researchers, healthcare professionals, and students. With the range of topics covered, from innovative treatments to diagnostic advancements, Prostate International serves as a vital resource for those committed to improving patient outcomes and driving the future of urological health.

Surgery in Practice and Science is a prominent academic journal published by Elsevier, focusing on the interdisciplinary fields of Otorhinolaryngology, Surgery, and Urology. With an ISSN of 2666-2620 and existing as an Open Access publication since 2020, this journal aims to facilitate widespread dissemination of vital research findings to enhance clinical practices and improve patient outcomes. Operating from the United Kingdom, this journal has established its place within the academic community, achieving a Q3 quartile ranking in 2023 across its respective categories, which reflects its commitment to quality and relevance in contemporary surgical discussions. Although the H-index is currently not specified, Surgery in Practice and Science has garnered recognition through its respective Scopus rankings, positioning it as a valuable resource for researchers, professionals, and students. With its objective of promoting knowledge exchange and innovation in surgical techniques and methodologies, this journal continues to play an essential role in its field, paving the way for future advancements in surgery and allied disciplines.

AKTUELLE UROLOGIE is a prominent peer-reviewed journal aimed at advancements in the field of urology, established in 1972 and continuing its commitment to high-quality research through 2024. Published by GEORG THIEME VERLAG KG in Germany, this journal serves as a platform for researchers, clinicians, and students to share innovative findings, critical reviews, and clinical studies that advance urological science and practice. While it currently holds a Q4 category ranking in Urology according to the 2023 metrics, its relevance and targeted contributions provide an invaluable resource for understanding the evolving challenges and treatment modalities within urological care. The journal is accessible via traditional subscription models, supporting a diverse audience in both academic and clinical settings. With an ISSN of 0001-7868 and E-ISSN of 1438-8820, AKTUELLE UROLOGIE continues to be an important reference point for professionals striving to stay abreast of the latest developments in the field.

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.

Urology Practice is a distinguished journal dedicated to advancing knowledge and practice in the field of urology. Published by Lippincott Williams & Wilkins, this journal has been pivotal in providing a platform for the dissemination of innovative research and clinical findings since its inception in 2014. With an ISSN of 2352-0779 and an E-ISSN of 2352-0787, the journal is indexed in Scopus, ranking #73 out of 120 in the Urology category, placing it in the 39th percentile. As part of the Q3 quartile in Urology for 2023, Urology Practice contributes significantly to the evolving landscape of urological medicine, offering vital insights to researchers, healthcare professionals, and students alike. While currently not an open-access journal, its valuable content remains accessible through traditional subscription-based models, catering to a global audience keen on enhancing their expertise in urology. The journal's commitment to excellence and its rigorous peer-review process ensure that published articles uphold the highest standards of scientific integrity, making it an essential resource for those engaged in urological research and clinical practice.

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.

Advances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.

Canadian Journal of Urology, published by CANADIAN J UROLOGY, is a prominent peer-reviewed journal dedicated to advancing the field of urology and its allied disciplines. Established in 2000, this journal has consistently aimed to provide a platform for comprehensive research, clinical studies, and innovative practices in urology and general medicine, ensuring that professionals remain at the forefront of medical advancements. With a reputation reflected in its 2023 Scopus ranking of Q3 in both Urology and Medicine (miscellaneous), the journal serves as an essential resource for researchers and practitioners seeking to enhance their knowledge and application of urological sciences. Although it is not an Open Access journal, its impactful findings contribute significantly to the medical community in Canada and beyond, promoting evidence-based practices and contributing to better patient outcomes. As the journal converges into 2024, it continues to welcome high-quality submissions that explore critical challenges and advancements in urology.